Complying with the Sunshine Act could be costly

04/29/2012 | MedCityNews.com

Drug and device makers could end up paying upwards of $200,000 in the first year the Sunshine Act is in force, driven by filing fees, legal fees and information technology upgrades, lawyer Sheva Sanders said at a LifeScience Alley conference. Eight states have laws regarding disclosure of financial relationships between manufacturers and health care providers, with varying fees and requirements.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX